Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae). (Q78435485)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

14 December 2019

title

Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae). (English)

1 reference

14 December 2019

1 reference

1 reference

1 reference

1 reference

(2R,6S)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(4S)-4-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

1 reference

6-(7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid

1 reference

(E,2S)-6-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

(E,2S)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid

1 reference

(2R,6S)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(E,2S)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

(2R,6S)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

1 reference

(2R,6S)-6-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

2-Methyl-4-oxo-6-(3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,8,9,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl)heptanoic acid

1 reference

1 reference

1 reference

(E,2S)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

1 reference

(2R,6S)-2-methyl-4-oxo-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

(2R,6S)-6-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(2R,6S)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

4-[(3S,7S,10S,11S,13R,14R,17S)-3,7,11-trihydroxy-4,4,10,13,14-pentamethyl-15-oxo-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

1 reference

1 reference

1 reference

1 reference

Polyporaceae

1 reference

based on heuristic

inferred from title

7,12-Dihydroxy-3,11,15,23-tetraoxolanost-8-en-26-oic acid

1 reference

1 reference

methyl 6-(3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoate

1 reference

1 reference

1 reference

YASUO KOMODA

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

14 December 2019

HIDEO NAKAMURA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

2

1 reference

14 December 2019

SHIGEMASA ISHIHARA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

3

1 reference

14 December 2019

MASARU UCHIDA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

4

1 reference

14 December 2019

HIROSHI KOHDA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

5

1 reference

14 December 2019

KAZUO YAMASAKI

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

6

1 reference

14 December 2019

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1985

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/33/11/33_11_4829/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.4829?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

14 December 2019

volume

33

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

14 December 2019

issue

11

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829

14 December 2019

page(s)

4829-4835

1 reference

14 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.33.4829?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.33.4829